Corgi Invest
@CorgiInvest
The New Breed of ETFs. Strategies Designed for Evolving Markets | Subsidiary of @UseCorgi | Disclosures:
Joined January 2026
103 Following 1.6K Followers
NEW: Cytokinetics $CYTK plans a fourth-quarter FDA filing for aficamten after its Phase 3 trial met the primary endpoint in symptomatic non-obstructive hypertrophic cardiomyopathy
